CD51 promotes gastric cancer stemness via blocking Numb-mediated Notch1 degradation
Cancer Letters · 2025-10 · 629 · 217886
DOI: 10.1016/j.canlet.2025.217886 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2025-10. Verfasst von Juzheng Peng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Diseases Center, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong, 518107, China; Scientific Research Center, T…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Neoplastic Stem Cells, Receptor, Notch1, Nerve Tissue Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Gastric cancer (GC) remains a lethal malignancy with poor prognosis largely due to cancer stem cell (CSC)-driven metastasis, recurrence, and chemoresistance. This study identifies CD51 (integrin αv) as a pivotal regulator of GC stemness and malignant progression. Bioinformatics analysis of TCGA data revealed significant CD51 upregulation in GC tissues, correlating with advanced tumor stage and poor survival. Functional assays demonstrated that CD51 enhances CSC properties, including tumorsphere formation, migration, invasion, and oxaliplatin resistance. Mechanistically, CD51 interacts with Numb, a negative regulator of Notch signaling, to divert Notch1 receptor trafficking from lysosomal degradation to plasma membrane recycling, thereby amplifying Notch pathway activation. Single-cell RNA sequencing and clinical validations confirmed CD51's superior correlation with stemness scores compared to canonical CSC markers. Pharmacological inhibition of CD51 using cilengitide suppressed CSC phenotypes in vitro and inhibited tumor growth in patient-derived organoids and xenograft models. These findings establish CD51 as a novel CSC biomarker and therapeutic target, offering a strategy to disrupt Notch-dependent stemness and chemoresistance in GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Digestive Diseases Center, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong, 518107, China; Scientific Research Center, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guan…
- Scientific Research Center, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong, 518107, China.
- Digestive Diseases Center, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong, 518107, China.
- School of Medicine, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, 518107, China.
- Department of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA. Electronic address: Zhijun-Zhou@ouhsc.edu.
- Digestive Diseases Center, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong, 518107, China. Electronic address: heyulong@mail.sysu.edu.cn.
Zitieren
APA
Peng, J., Yin, Y., Liu, X., Deng, C., Wang, P., Hu, X., Chen, J., Peng, S., Li, K., Zhong, L., Zhou, Z., He, Y., & Wang, J. (2025). CD51 promotes gastric cancer stemness via blocking Numb-mediated Notch1 degradation. Cancer Letters, 629, 217886. https://doi.org/10.1016/j.canlet.2025.217886
Vancouver
Peng J, Yin Y, Liu X, Deng C, Wang P, Hu X, et al. CD51 promotes gastric cancer stemness via blocking Numb-mediated Notch1 degradation. Cancer Letters. 2025;629:217886. doi:10.1016/j.canlet.2025.217886
BibTeX
@article{Peng2025,
author = {Peng, Juzheng and Yin, Yuehan and Liu, Xuan and Deng, Cuncan and Wang, Peizhu and Hu, Xiaojie and Chen, Jiefu and Peng, Sicheng and Li, Kuan and Zhong, Li and Zhou, Zhijun and He, Yulong and Wang, Jiancheng},
title = {CD51 promotes gastric cancer stemness via blocking Numb-mediated Notch1 degradation},
journal = {Cancer Letters},
year = {2025},
volume = {629},
pages = {217886},
doi = {10.1016/j.canlet.2025.217886}
}
EUVIMED